RxDoctor Payments Data

Boyd Viers, MD

Urology · Rochester, MNNPI 1922319359

Payments from drug & device makers

What this record shows

Boston Scientific accounts for 70.1% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $1,200 and has fallen 90.8% since, to $110 in 2025.

$2,354in general payments, 2019–2025

Across 15 payments — averaging $156.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • LSI Solutions Inc$204
  • Medtronic$162
  • Johnson & Johnson$82
  • Conmed Corporation$77
  • Astellas Pharma US Inc$75
  • plus $105 from 2 others
$5,000in research payments, 2019–2025

Across 1 payment — averaging $5000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Urotronic, Inc$5K

What the payments were for

  • Speaking & faculty fees$1,20051%
  • Food & beverage$1,15449%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,354 in reported general payments places this provider in the 70th percentile of 247 urology providers in Minnesota.

See all urology providers in Minnesota

Medicare billing

Part B allowed, 2024
$222,773
Medicare patients
293
Services billed
6,754

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →